APA (7th ed.) Citation

Ricci, R. P., Quesada, A., Almendral, J., Arribas, F., Wolpert, C., Adragao, P., . . . Santini, M. (2009). Dual-chamber implantable cardioverter defibrillators reduce clinical adverse events related to atrial fibrillation when compared with single-chamber defibrillators: A subanalysis of the DATAS trial. Europace: European pacing, arrhythmias, and cardiac electrophysiology: journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 11(5), 587.

Chicago Style (17th ed.) Citation

Ricci, Renato Pietro, et al. "Dual-chamber Implantable Cardioverter Defibrillators Reduce Clinical Adverse Events Related to Atrial Fibrillation When Compared with Single-chamber Defibrillators: A Subanalysis of the DATAS Trial." Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology 11, no. 5 (2009): 587.

MLA (9th ed.) Citation

Ricci, Renato Pietro, et al. "Dual-chamber Implantable Cardioverter Defibrillators Reduce Clinical Adverse Events Related to Atrial Fibrillation When Compared with Single-chamber Defibrillators: A Subanalysis of the DATAS Trial." Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, vol. 11, no. 5, 2009, p. 587.